TURBOCAR

Serial Number 97650058
733

Registration Progress

Application Filed
Oct 27, 2022
Under Examination
May 2, 2023
Approved for Publication
Mar 7, 2023
Published for Opposition
Mar 7, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 4 Granted
Due: Nov 02, 2025 109 days

Trademark Image

TURBOCAR

Basic Information

Serial Number
97650058
Filing Date
October 27, 2022
Published for Opposition
March 7, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Apr 2, 2025
Application
Pending
Classes
005

Rights Holder

Allogene Therapeutics, Inc.

03
Address
210 E. Grand Avenue
South San Francisco, CA 94080

Ownership History

Allogene Therapeutics, Inc.

Original Applicant
03
South San Francisco, CA

Allogene Therapeutics, Inc.

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
Colleen Ganin

USPTO Deadlines

Next Deadline
109 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
November 02, 2025
Extension Available
Until May 02, 2024

Application History

31 events
Date Code Type Description Documents
Apr 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 2, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 2, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 2, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 28, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 28, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Feb 28, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 28, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 31, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 31, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 31, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 31, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 2, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 1, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 1, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
May 1, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 27, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 25, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 25, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 25, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 2, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 7, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 7, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 15, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 31, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 5, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 5, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 5, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 4, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 10, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 31, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy

Classification

International Classes
005